Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Patient with Atopic Dermatitis' Needs for Self-management Support - Flexible Patient Centred Consultations [NA]
An update on an ongoing clinical trial focusing on self-management support and flexible, patient-centered consultations for individuals with…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: The Role of Human Milk Oligosaccharides and Microbiomes on Infantile Colic and Atopic Dermatitis in Term Infants
This clinical trial examines the impact of human milk oligosaccharides and microbiome factors on infantile colic and atopic dermatitis in te…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Ocular Comorbidity in Atopic Dermatitis
Update on a clinical trial investigating ocular involvement in atopic dermatitis, focusing on atopic keratoconjunctivitis; the study is curr…
-
CLINICAL_TRIALS research · 2024-11-13Clinical Trial Update: A Clinical Study to Assess the Safety and Effectiveness of Test Products in Mild to Moderate Atopic Dermatitis (AD) Patients. [NA]
A clinical study is planned to assess the safety and effectiveness of test products in adults with mild to moderate atopic dermatitis. The t…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Targeted Investigation of Microbiome Elimination [Phase 1]
Phase 1 trial investigating targeted microbiome elimination for atopic dermatitis was terminated. Results were posted on 2024-11-12.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis [Phase 2]
Phase 2 clinical trial of CM310 in pediatric patients with moderate-to-severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: The Study of CM310 in Patients With Atopic Dermatitis [Phase 2]
This document announces the completion of a Phase 2 clinical trial evaluating CM310 in adults with moderate-to-severe atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: A Study of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis [Phase 3]
Phase 3 trial CM310 in moderate-to-severe Atopic Dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial update evaluating the dose-dependent efficacy and safety of EC-18 in adults with moderate to severe Atopic Dermatit…
-
CLINICAL_TRIALS withdrawal · 2024-11-07Clinical Trial Update: Investigation of Flare and Remission in Subjects With Atopic Dermatitis [Phase 4]
A Phase 4 clinical trial investigating flare and remission in subjects with atopic dermatitis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine [Phase 3]
A Phase 3 study evaluating Lebrikizumab in combination with topical corticosteroids for atopic dermatitis not adequately controlled with cyc…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis. [Phase 1]
A Phase 1 study comparing Ruxolitinib topical cream 1.5% (Taro Pharmaceuticals) with OPZELURA (Ruxolitinib) Cream for mild-to-moderate atopi…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: A Clinical Trial in Subjects With Atopic Dermatitis (Part 1) [Phase 2]
Phase 2 clinical trial in atopic dermatitis completed; this update provides status for Part 1 of the study.
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis [Phase 3]
Phase 3 trial update reporting long-term safety and efficacy of nemolizumab in adults with moderate-to-severe atopic dermatitis; status indi…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis
Pfizer's expanded access protocol for abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis is no longer available…
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis [Phase 2]
Phase 2 study ATI-1777 in patients aged 12-65 with mild to severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis [Phase 2]
A Phase 2 trial of CM310 injection for moderate-to-severe atopic dermatitis has completed; the update summarizes the study status and outcom…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: AI App for Management of Atopic Dermatitis [NA]
An ongoing clinical trial in West China Hospital is evaluating an AI-based app for managing atopic dermatitis, and the study is currently re…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients [NA]
This clinical trial update reports skin responses and T cell immunology following house dust mite exposure in individuals with sensitized at…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis [Phase 1, Phase 2]
Phase 1/2 trial CM310 in pediatric patients with moderate-to-severe atopic dermatitis has completed; the study was conducted by Keymed Biosc…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis [Phase 3]
A Phase 3 trial evaluated roflumilast, a PDE4 inhibitor, for the management of atopic dermatitis; the study has completed and results were p…
-
CLINICAL_TRIALS withdrawal · 2024-10-09Clinical Trial Update: An Investigation of a Multi-Function Skincare Product to Improve Aging, Eczema, and Acne Outcomes [NA]
A clinical trial evaluating a multi-function skincare product for acne and eczema (with considerations for skin aging) has been withdrawn; s…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: Goat Infant Formula Feeding and Eczema (the GIraFFE Study) [NA]
The GIraFFE study on goat infant formula feeding is currently active but not recruiting, sponsored by the Dairy Goat Co-operative (New Zeala…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis [Phase 4]
Phase 4 trial evaluating dupilumab to improve sleep, circadian function and pruritus in children with moderate-to-severe atopic dermatitis; …
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II) [Phase 3]
Phase 3 INTEGUMENT-II trial evaluating roflumilast, a PDE4 inhibitor, for the management of atopic dermatitis has completed and results have…